High-throughput screening of 66,000 compounds using competitive binding of peptides comprising the BH3 domain to anti-apoptotic Bfl-1 led to the identification of 14 validated 'hits' as inhibitors of Bfl-1. N-Aryl maleimide 1 was among the validated 'hits'. A chemical library encompassing over 280 analogs of 1 was prepared following a two-step synthesis. Structure-activity studies for inhibition of Bfl-1 by analogs of N-aryl maleimide 1 revealed a preference for electron-withdrawing substituents in the N-aryl ring and hydrophilic amines appended to the maleimide core. Inhibitors of Bfl-1 are potential development candidates for anti-cancer therapeutics. (C) 2010 Elsevier Ltd. All rights reserved.
Compounds that bind to Bfl-1 as well as conjugates of such compounds are provided. Various embodiments additionally provide methods of using such compounds to identify additional anti-apoptotic Bfl-1 binding compounds. Methods of using such compounds to increase apoptosis in a cell are also provided.
[EN] CHEMICAL INHIBITORS OF BFL-1 AND RELATED METHODS<br/>[FR] INHIBITEURS CHIMIQUES DE BFL-1 ET PROCÉDÉS CONCERNÉS
申请人:BURNHAM INST
公开号:WO2008157003A2
公开(公告)日:2008-12-24
[EN] Compounds that bind to BfI-1 as well as conjugates of such compounds are provided. Various embodiments additionally provide methods of using such compounds to identify additional anti-apoptotic BfI- 1 binding compounds. Methods of using such compounds to increase apoptosis in a cell are also provided. [FR] L'invention concerne des composés qui se lient à BfI-1 ainsi que des conjugués de tels composés. Divers modes de réalisation fournissent de plus des procédés d'utilisation de tels composés pour identifier des composés se liant à BfI-1 anti-apoptotiques supplémentaires. Des procédés d'utilisation de tels composés pour augmenter l'apoptose dans une cellule sont également fournis.